Lynch syndrome: History and current status

Disease Markers

Volumn 20, Issue 4-5, 2004, Pages 181-198

  Lynch, Henry T ^a   Lynch, Jane F ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER FAMILY; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; COLORECTAL CANCER; CONFERENCE PAPER; FAMILIAL CANCER; GENE MUTATION; GENETIC MODEL; HUMAN; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; MUIR TORRE SYNDROME; MUTATION; NORTH AMERICA; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH AMERICA;

EID: 12844275378     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/460240     Document Type: Conference Paper

References (140)

1. International Agency for Research on Cancer, Globocan 2000, International Agency for Research on Cancer, Available at: http://www-dep.iarc.fr/globocan/ globocan.html. Accessed March 26, 2003.
2. S.J. Laken, G.M. Petersen, S.B. Gruber, C. Oddoux, H. Ostrer and F.M. Giardiello et al., Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC, Nat Genet 17 (1997), 79-83.
3. N. Al-Tassan, N.H. Chmiel, J. Maynard and N. Fleming, Inherited variants of MYH associated with somatic G:C -< T:A mutations in colorectal tumors, Nat Genet 30 (2002), 227-232.
4. O.M. Sieber, L. Lipton, M. Crabtree, K. Heinimann, P. Fidalgo and R.K.S. Phillips et al., Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH, N Engl J Med 348 (2003), 791-799.
5. H.T. Lynch, A.J. Krush and H. Guirgis, Genetic factors in families with combined gastrointestinal and breast cancer, Am J Gastroenterol 59 (1973), 31-40.
6. H. Meijers-Heijboer, J. Wijnen, H. Vasen, M. Wasielewski, A. Wagner and A. Hollestelle et al., The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype, Am J Hum Genet 72 (2003), 1308-1314.
7. B. Vogelstein and K.W. Kinzler, eds, The Genetic Basis of Human Cancer, New York: McGraw-Hill, 1998.
8. T.C. Smyrk and H.T. Lynch, Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers, Eur J Cancer 35 (1999), 171-172.
9. J.A. Bufill, Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location, Ann Intern Med 113 (1990), 779-788.
10. O.K. Glebov, L.M. Rodriguez, K. Nakahara, J. Jenkins, J. Cliatt and C-J. Humbyrd et al., Distinguishing right from left colon by the pattern of gene expression, Cancer Epidemiol Biomarkers Prev 12 (2003), 755-762.
11. H.T. Lynch and A. de la Chapelle, Genomic medicine: hereditary colorectal cancer, N Engl J Med 348 (2003), 919-932.
12. H.T. Lynch, Family Information Service and hereditary cancer, Cancer 91 (2001), 625-628.
13. P. Watson and H.T. Lynch, Extracolonic cancer in hereditary nonpolyposis colorectal cancer, Cancer 71 (1993), 677-685.
14. P. Watson and H.T. Lynch, The tumor spectrum in HNPCC, Anticancer Res 14 (1994), 1635-1640.
15. H.T. Lynch, M.W. Shaw, C.W. Magnuson, A.L. Larsen and A.J. Krush, Hereditary factors in cancer: study of two large Midwestern kindreds, Arch Intern Med 117 (1966), 206-212.
16. H.T. Lynch and A.J. Krush, Cancer family G revisited: 1895-1970, Cancer 27 (1971), 1505-1511.
17. S.S. Chang and W.H. Hildemann, Inheritance of susceptibility to polyoma virus in mice, J Natl Cancer Inst 33 (1964), 303-313.
18. A.S. Warthin, Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913, Arch Intern Med 12 (1913), 546-555.
19. H. Yan, N. Papadopoulos, G. Marra, C. Perrera, J. Jiricny and C.R. Boland et al., Conversion of diploidy to haploidy: individuals susceptible to multigene disorders may now be spotted more easily. Nature 403 (2000), 723-724.
20. H.T. Lynch and A.J. Krush, The cancer family syndrome and cancer control, Surg Gynecol Obstet 132 (1971), 247-250.
21. H.T. Lynch, A.J. Krush and A.L. Larsen, Heredity and multiple primary malignant neoplasms: six cancer families, Am J Med Sci 254 (1967), 322-329.
22. P.M. Lynch, H.T. Lynch and R.E. Harris, Hereditary proximal colonic cancer, Dis Colon Rectum 20 (1977), 661-668.
23. M. Lipkin, W.E. Blattner, J.F. Fraumeni, Jr., H.T. Lynch, E. Deschner and S. Winawer, Tritiated thymidine (phi p, phi h) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 43 (1983), 1899-1904.
24. H.F.A. Vasen, J-P. Mecklin, P. Meera Khan and H.T. Lynch, The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer (ICG-HNPCC), Dis Colon Rectum 34 (1991), 424-425.
25. H.F.A. Vasen, P. Watson, J-P. Mecklin and H.T. Lynch, ICG-HNPCC. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC, Gastroenterology 116 (1999), 1453-1456.
26. M.A. Rodriguez-Bigas, C.R. Boland, S.R. Hamilton, D.E. Henson, J.R. Jass and P.M. Khan et al., A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines, J Natl Cancer Inst 89 (1997), 1758-1762.
27. W.A. Albano, J.A. Recabaren, H.T. Lynch, A.S. Campbell, J.A. Mailliard and C.H. Organ et al., Natural history of hereditary cancer of the breast and colon, Cancer 50 (1982), 360-363.
28. H.T. Lynch, P. Watson, S.J. Lanspa, J.N. Marcus, T.C. Smyrk and R. Fitzgibbons, Jr. et al., Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch Syndromes I and II), Dis Colon Rectum 31 (1988), 439-444.
29. H.T. Lynch, K. Lin, T. Smyrk, P. Watson, A. Thorson and M. Shashidharan et al., Colorectal cancer, pathology staging and survival in HNPCC, ASCO Program/Proceedings 16 (1997), 530a, Abstract.
30. P. Watson, K. Lin, M.A. Rodriguez-Bigas, T. Smyrk, S. Lemon and M. Shashidharan et al., Colorectal carcinoma survival among hereditary nonpolyposis colorectal cancer family members, Cancer 83 (1998), 259-266.
31. J.R. Jass, T.C. Smyrk, S.M. Stewart, M.R. Lane, S.J. Lanspa and H.T. Lynch, Pathology of hereditary non-polyposis colorectal cancer, Anticancer Res 14 (1994), 1631-1634.
32. T.C. Smyrk, P. Watson, K. Kaul and H.T. Lynch, Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal cancer, Cancer 91 (2001), 2417-2422.
33. J.I. Risinger, J.C. Barrett, P. Watson, H.T. Lynch and J. Boyd, Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary non-polyposis colorectal cancer syndrome, Cancer 77 (1996), 1836-1843.
34. Y.J. Park, K-H. Shin and J-G. Park, Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea, Clin Cancer Res 6 (2000), 2994-2998.
35. H.T. Lynch and A. de la Chapelle, Genetic susceptibility to non-polyposis colorectal cancer, J Med Genet 36 (1999), 801-818.
36. J.R. Jass and S.M. Stewart, Evolution of hereditary non-polyposis colorectal cancer, Gut 33 (1992), 783-786.
37. J.R. Jass, Colorectal adenoma progression and genetic change: is there a link? Ann Med 27 (1995), 301-306.
38. H.T. Lynch, P.M. Lynch, J. Pester and R.M. Fusaro, The cancer family syndrome: rare cutaneous phenotypic linkage of Torre's syndrome, Arch Intern Med 141 (1981), 607-611.
39. H.T. Lynch, P.M. Lynch, J.A. Pester and R.M. Fusaro, Sebaceous neoplasia and visceral cancer (Torre's syndrome) and its relationship to the cancer family syndrome, in: Cancer-associated Genodermatoses, H.T. Lynch and R.M. Fusaro, eds, New York: Van Nostrand Reinhold, 1982, pp. 366-393.
40. H.T. Lynch, R.M. Fusaro, L. Roberts, G.J. Voorhees and J.F. Lynch, Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome, Br J Dermatol 113 (1985), 295-301.
41. H.T. Lynch and R.M. Fusaro, Muir-Torre syndrome: heterogeneity, natural history, diagnosis, and management, Prob Gen Surg 10 (1993), 1-14.
42. H.T. Lynch, R. Leibowitz, T. Smyrk, R.M. Fusaro, J.F. Lynch and A. Smith et al., Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review, Am J Gastroenterol 94 (1999), 575-580.
43. J.R. Jass, S.M. Stewart, J. Stewart and M.R. Lane, Hereditary nonpolyposis colorectal cancer - morphologies, genes and mutations, Mutation Res 310 (1994), 125-133.
44. J.R. Jass, Natural history of hereditary non-polyposis colorectal cancer, Journal of Tumor Marker Oncology 10 (1995), 65-71.
45. R. Sankila, L.A. Aaltonen, H.J. Jarvinen and J-P. Mecklin, Better survival rates in patients with MLH1-associated hereditary colorectal cancer, Gastroenterology 110 (1996), 682-687.
46. J-P. Mecklin and H.J. Jarvinen, Clinical features of colorectal carcinoma in cancer family syndrome, Dis Colon Rectum 29 (1986), 160-164.
47. H.T. Lynch, T. Smyrk, S. Lanspa, J. Marcus, B.M. Bowman and P. Watson et al., Pathology and genetic markers of colorectal cancer in Lynch Syndromes I and II, J Tumor Marker Oncol 3 (1988), 341-350.
48. N.M. Gibbs, Undifferentiated carcinoma of the large intestine, Histopathology 1 (1977), 77-84.
49. M.R. Jessurun and J.C. Manivel, Cecal, poorly differentiated adenocarcinomas, medullary-type, Mod Pathol 5 (1992), 43A, Abstract.
50. H. Kim, J. Jen, B. Vogelstein and S.R. Hamilton, Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences, Am J Pathol 145 (1994), 148-156.
51. S.N. Thibodeau, A.J. French, P.C. Roche, J.M. Cunningham, D.J. Tester and N.M. Lindor et al., Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes, Cancer Res 56 (1996), 4836-4840.
52. T.C. Smyrk, H.T. Lynch, P.A. Watson and H.D. Appelman, Histologic features of hereditary nonpolyposis colorectal carcinoma, in: Hereditary Colorectal Cancer, J. Utsunomiya and H.T. Lynch, eds, Tokyo: Springer-Verlag, 1990, pp. 357-362.
53. D.M. Graham and H.D. Appelman, Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator, Mod Pathol 3 (1990), 332-335.
54. R. Gryfe, H. Kim, E.T.K. Hsieh, M.D. Aronson, E.J. Holowaty and S.B. Bull et al., Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer, N Engl J Med 342 (2000), 69-77.
55. K.M. Lin, M. Shashidharan, C.A. Ternent, A.G. Thorson, G.J. Blatchford and M.A. Christensen et al., Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population, Dis Colon Rectum 41 (1998), 428-433.
56. P. Peltomäki, L. Aaltonen, P. Sistonen, L. Pylkkänen, J-P. Mecklin and H. Järvinen et al., Genetic mapping of a locus predisposing to human colorectal cancer, Science 260 (1993), 810-812.
57. A. Lindblom, P. Tannergard, B. Werelius and M. Nordenskjold, Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer, Nat Genet 5 (1993), 279-282.
58. L.A. Aaltonen, P. Peltomaki, F.S. Leach, P. Sistonen, L. Pylkkanen and J-P. Mecklin et al., Clues to the pathogenesis of familial colorectal cancer, Science 260 (1993), 812-816.
59. S.N. Thibodeau, G. Bren and D. Schaid, Microsatellite instability in cancer of the proximal colon, Science 260 (1993), 816-819.
60. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French and R.M. Goldberg et al., Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer, N Engl J Med 349 (2003), 247-257.
61. A. de la Chapelle, Microsatellite instability, N Engl J Med 349 (2003), 209-210.
62. R. Fishel, M.K. Lescoe, M.R.S. Rao, N.G. Copeland, N.A. Jenkins and J. Garber et al., The human mutator gene homolog MLH2 and its association with hereditary nonpolyposis colon cancer, Cell 75 (1993), 1027-1038.
63. F.S. Leach, N.C. Nicolaides, N. Papadopoulos, B. Liu, J. Jen and R. Parsons et al., Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer, Cell 75 (1993), 1215-1225.
64. C.E. Bronner, S.M. Baker, P.T. Morrison, G. Warren, L.G. Smith and M.K. Lescoe et al., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer, Nature 368 (1994), 258-261.
65. N. Papadopoulos, N.C. Nicolaides, Y-F. Wei, S.M. Ruben, K.C. Carter and C.A. Rosen et al., Mutation of a mutL homolog in hereditary colon cancer, Science 263 (1994), 1625-1629.
66. F. Palombo, M. Hughes, J. Jiricny, O. Truong and J. Hsuan, Mismatch repair and cancer, Nature 367 (1994), 417.
67. N.C. Nicolaides, N. Papadopoulos, B. Liu, Y-F. Wei, K.C. Carter and S.M. Ruben et al., Mutations of two PMS homologues in hereditary nonpolyposis colon cancer, Nature 371 (1994), 75-80.
68. B. Liu, R.E. Parsons, S.R. Hamilton, G.M. Petersen, H.T. Lynch and P. Watson et al., hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds, Cancer Res 54 (1994), 4590-4594.
69. R. Parsons, G.M. Li, M.J. Longley, W-H. Fang, N. Papadopoulos and J. Jen et al., Hypermutability and mismatch repair deficiency in RER + tumor cells, Cell 75 (1993), 1227-1236.
70. H.T. Lynch, T. Smyrk and J. Lynch, An update of HNPCC (Lynch syndrome), Cancer Genet Cytogenet 93 (1997), 84-99.
71. P. Peltomäki, Role of DNA mismatch repair defects in the pathogenesis of human cancer, J Clin Oncol 21 (2003), 1174-1179.
72. M. Miyaki, M. Konishi, K. Tanaka, R. Kikuchi-Yanoshita, M. Muraoka and M. Yasuno et al., Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer, Nat Genet 17 (1997), 271-272.
73. J. Wijnen, W. de Leeuw, H. Vasen, H. van der Klift, P. Møller and A. Stormorken et al., Familial endometrial cancer in female carriers of MSH6 germline mutations, Nat Genet 23 (1999), 142-144.
74. E. Renkonen, H. Lohi, Y. Zhang, R. Salovaara, W. Abdel-Rahman and A-L. Moisio et al., Expression changes in predisposition to HNPCC and FAP: a population based study, Familial Cancer 2(Suppl 1) (2003), 37, Abstract.
75. A. Lindblom, Different mechanisms in the tumorigenesis of proximal and distal colon cancers, Curr Opin Oncol 13 (2001), 63-69.
76. J.R. Jass, Clinical significance of early-onset sporadic colorectal cancer with microsatellite instability, Dis Colon Rectum 46 (2003), 1305-1309.
77. J-G. Park, H.F.A. Vasen, Y.J. Park, K.J. Park, P. Peltomaki and M. Ponzo de Leon et al., Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study, Int J Colorectal Dis 17 (2002), 109-114.
78. H. Itoh, R.S. Houlston, C. Harocopos and J. Slack, Risk of cancer death in first-degree relatives of patients with hereditary nonpolyposis cancer syndrome (Lynch Type II): a study of 130 kindreds in the United Kingdom, Br J Surg 77 (1990), 1367-1370.
79. J.R. Jass, S.M. Stewart, D. Schroeder and M.R. Lane, Screening for hereditary nonpolyposis colorectal cancer in New Zealand, Eur J Gastroenterol Hepatol 4 (1992), 523-527.
80. H.F. Vasen, F.C.A. Hartog Jager, F.H. Menko and F.M. Nagengast, Screening for hereditary nonpolyposis colorectal cancer: a study of 22 kindreds in the Netherlands, Am J Med 86 (1989), 278-281.
81. M. Ponz de Leon, R. Sassatelli, C. Sacchetti, G. Zanghieri, A. Scalmati and L. Roncucci, Familial aggregation of tumors in the 3-year experience of a population-based colorectal cancer registry, Cancer Res 49 (1989), 4344-4348.
82. H. Abusamra, S. Maximova, S. Bar-Meir, M. Krispin and H.H. Rotmensch, Cancer family syndrome of Lynch, Am J Med 83 (1987), 981-983.
83. J-P. Mecklin, H.J. Jarvinen and P. Peltokallio, Cancer family syndrome: genetic analysis of 22 Finnish kindreds, Gastroenterology 30 (1986), 328-333.
84. C. Sarroca, W.A. Ferreira and R. Quadrelli, Cáncer colónico familiar sin poliposis: enfoque clínico y anátomo- patológico, Perspectivas de estudio genético, Cir del Uruguay 47 (1977), 515-520.
85. J.P. Mecklin, Frequency of hereditary nonpolyposis colorectal carcinoma, Gastroenterology 93 (1987), 1021-1025.
86. National Institutes of Health, The diagnostic guidelines for hereditary non-polyposis colorectal cancer and microsatellite instability meeting. 03 Dec 11; NIH, 2002.
87. C. Sarroca, N. Alfano, G.T. Bendin, A. Della Valle, C. Dominguez and R. Quadrelli et al., Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay, Dis Colon Rectum 43 (2000), 353-362.
88. C. Sarroca, P. Peltomäki, N. Alfano, G. Tedesco, A. Della Valle and A. Dominguez et al., Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay, Cancer Genet Cytogenet 142 (2003), 13-20.
89. T.E. Raevaara, C. Vaccaro, W.M. Abdel-Rahman, E. Mocetti, S. Bala and K.E. Lönnqvist et al., Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein, Gastroenterology 125 (2003), 501-509.
90. A. de la Chapelle and F.A. Wright, Linkage disequilibrium mapping in isolated populations: the example of Finland revisited, Proc Natl Acad Sci USA 95 (1998), 12416-12423.
91. M. Nyström-Lahti, P. Sistonen, J-P. Mecklin, L. Pylkkänen, L.A. Aaltonen and H. Järvinen et al., Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families, Proc Natl Acad Sci USA 91 (1994), 6054-6058.
92. M. Nyström-Lahti, Y. Wu, A-L. Moisio, R.M.W. Hofstra, J. Osinga and J-P. Mecklin et al., DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary nonpolyposis colorectal cancer, Hum Mol Genet 5 (1996), 763-769.
93. A-L. Moisio, P. Sistonen, J. Weissenbach, A. de la Chapelle and P. Peltomaki, Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer, Am J Hum Genet 59 (1996), 1243-1251.
94. H.J. Järvinen, M. Aarnio, H. Mustonen, K. Aktan-Collan, L.A. Aaltonen and P. Peltomäki et al., Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer, Gastroenterology 118 (2000), 829-834.
95. D. Kluckhorn and D. Leighton, The Navajo. Cambridge, Mass.: Harvard University Press, 1974.
96. H.T. Lynch, T. Drouhard, H.F.A. Vasen, J. Cavalieri, J. Lynch and S. Nord et al., Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred, Cancer 77 (1996), 30-35.
97. M.L. Sievers, Cancer of the digestive system among American Indians, Ariz Med 33 (1976), 15-20.
98. E.T. Creagan and J.F. Fraumeni, Cancer mortality among American Indians, J Natl Cancer Inst 49 (1972), 959-967.
99. H.T. Lynch, T. Drouhard, S. Lanspa, T. Smyrk, P. Lynch and J. Lynch et al., Mutation of an mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer, J Natl Cancer Inst 86 (1994), 1417-1419.
100. H.T. Lynch, S.M. Coronel, R. Okimoto, H. Hampel, K. Sweet and J.F. Lynch et al., An American founder mutation of the MLH2 gene may account for a significant proportion of all Lynch syndrome cases in the United States, JAMA, in press.
101. A. Wagner, H. van der Klift, P. Franken, J. Wijnen, C. Breukel and V. Bezrookove et al., A 10 Mb paracentric inversion of chromosome arm 2p inactivates MLH2 and is responsible for HNPCC in a North-American kindred, Genes Chromosomes Cancer 35 (2002), 49-57.
102. H.T. Lynch, J. Paulson, M. Severin, J. Lynch and P. Lynch, Failure to diagnose hereditary colorectal cancer and its medicolegal implications: a hereditary nonpolyposis colorectal cancer case, Dis Colon Rectum 42 (1999), 31-35.
103. P.M. Calvert and H. Frucht, The genetics of colorectal cancer, Ann Intern Med 137 (2002), 603-612.
104. C. Soravia, T. Berk and Z. Cohen, Genetic testing and surgical decision making in hereditary colorectal cancer, Int J Colorectal Dis 15 (2000), 21-28.
105. H.F.A. Vasen, F.M. Nagengast and P.M. Khan, Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome), Lancet 345 (1995), 1183-1184.
106. J. Church, Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance, Am J Gastroenterol 93 (1998), 2289-2290.
107. D.K. Rex, C.S. Cutler, G.T. Lemmel, E.Y. Rahmani, D.W. Clark and D.J. Helper et al., Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies, Gastroenterology 112 (1997), 24-28.
108. H.T. Lynch, Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 39 (1996), 109-110.
109. J.M. Church, Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer, Ann Med 28 (1996), 479-482.
110. C.L. Scaife and M.A. Rodriguez-Bigas, Lynch syndrome: Implications for the surgeon, Clinical Colorectal Cancer 3 (2003), 92-98.
111. M.A. Rodriguez-Bigas and N.J. Petrelli, Management of hereditary colon cancer syndromes, in: Colorectal Cancer: Multimodality Management, L.B. Saltz, ed., Totowa, NJ: Humana Press, 2002, pp. 99-114.
112. M.A. Rodriguez-Bigas, Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer, Has the time come? Cancer 78 (1996), 199-201.
113. H.T. Lynch, J.F. Lynch and R. Fitzgibbons, Role of prophylactic colectomy in Lynch syndrome, Clinical Colorectal Cancer 3 (2003), 99-101.
114. S.E. Green, D.M. Bradburn, J.S. Varma and J. Burn, Hereditary nonpolyposis colorectal cancer, Int J Colorectal Dis 13 (1998), 3-12.
115. S. Syngal, J.C. Weeks, D. Schrag, J.E. Garber and K.M. Kuntz, Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations, Ann Intern Med 129 (1998), 787-796.
116. S. Anwar, C. Hall, J. White, M. Deakin, W. Farrell and J.B. Elder, Hereditary nonpolyposis colorectal cancer: an updated review, Eur J Surg Oncol 26 (2000), 635-645.
117. G. Möslem, S. Pistorius, H. Saeger and H.K. Schackert, Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome, Langenbaecks Arch Surg 288 (2003), 9-16.
118. A. Krush, H.T. Lynch and C. Magnuson, Attitudes toward cancer in a cancer family: implications for cancer detection, Am J Med Sci 249 (1965), 432-438.
119. H.T. Lynch, R.L. Tips, A.J. Krush and C. Magnuson, Family centered genetic counseling: role of the physician and the medical genetics clinic, Nebr State Med J 50 (1965), 155.
120. G. Cristofaro, H.T. Lynch, M.L. Caruso, A. Attolini, G. Di-Matteo and P. Giorgio et al., New phenotypic aspects in a family with Lynch syndrome II, Cancer 60 (1987), 51-58.
121. H.T. Lynch, P.M. Lynch and R.E. Harris, Minimal genetic findings and their cancer control implications: a family with the cancer family syndrome, JAMA 240 (1978), 535-538.
122. R.M. Fusaro, H.T. Lynch, J. Pester and P.M. Lynch, Torre's syndrome as phenotypic expression of cancer family syndrome, Arch Dermatol 116 (1980), 986-987.
123. H.T. Lynch, T.J. Drouhard, G.S. Schuelke, K.A. Biscone, J.F. Lynch and B.S. Danes, Hereditary nonpolyposis colorectal cancer in a Navajo Indian family. Cancer Genet Cytogenet 15 (1985), 209-213.
124. P.M. Lynch, M.J. Wargovich, H.T. Lynch, C. Palmer, S. Lanspa and T. Drouhard et al., A follow-up study of colonic epithelial proliferation as a biomarker in a Native-American family with hereditary nonpolyposis colorectal cancer, J Natl Cancer Inst 83 (1991), 951-954.
125. H.T. Lynch, T. Drouhard, S.J. Lanspa, P. Lynch, E. Bronson and J.F. Lynch, Lynch syndrome II in a Navajo family: a revisit, American Indian Culture and Research Journal 16 (1992), 1-13.
126. M. Nystrom-Lahti, R. Parsons, P. Sistonen, L. Pylkkanen, L.A. Aaltonen and F.S. Leach et al., Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage, Am J Hum Genet 55 (1994), 659-665.
127. C.R. Boland and F.J. Troncale, Familial colonic cancer without antecedent polyposis, Ann Intern Med 100 (1984), 700-701.
128. M.A. Tempero, M.M. Jacobs, H.T. Lynch, C.L. Graham and A.J. Blotcky, Serum and hair selenium levels in hereditary nonpolyposis colorectal cancer, Biological Trace Element Research 6 (1984), 51-55.
129. H.F.A. Vasen, P. Watson, J-P. Mecklin, P.M. Khan and H.T. Lynch, The International Collaborative Group on HNPCC, Anticancer Res 14 (1994), 1661-1664.
130. H.T. Lynch, J.N. Marcus, P. Watson and J. Lynch, Familial breast cancer, cancer family syndromes, and predisposition to breast neoplasms, in: The Breast, K. Bland and E.M. Copeland, eds, Philadelphia: W.B.Saunders Co., 1991, pp. 262-291.
131. C.R. Boland, T.F. Chen, S.J. Rinderle, J.H. Resau, G.D. Luk and H.T. Lynch et al., Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells [published erratum appears in, Cancer Res 15:52(14) (July 1992), 4066, Cancer Res 51 (1991), 657-665.
132. C.R. Boland, M.A. Martin and I.J. Goldstein, Lectin reactivities as intermediate biomarkers in premalignant colorectal epithelium, J Cell Biochem Suppl 16G (1992), 103-109.
133. G. Marra and C.R. Boland, Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives, J Natl Cancer Inst 87 (1995), 1114-1125.
134. M.T. Hawn, A. Umar, J.M. Carethers, G. Marra, T.A. Kunkel and C.R. Boland et al., Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint, Cancer Res 55 (1995), 3721-3725.
135. C.R. Boland, Roles of the DNA mismatch repair genes in colorectal tumorigenesis, Int J Cancer 69 (1996), 47-49.
136. Y. Akiyama, H. Sato, T. Yamada, H. Nagasaki, A. Tsuchiya and R. Abe et al., Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred, Cancer Res 57 (1997), 3920-3923.
137. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman and R.W. Burt et al., A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res 58 (1998), 5248-5257.
138. M.A. Rodriguez-Bigas, H.F.A. Vasen, H.T. Lynch, P. Watson, T. Myrhøj, H.J. Järvinen et al., Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma, Cancer 83 (1998), 240-244.
139. S.C. Huang, J.E. Lavine, P.S. Boland, R.O. Newbury, R. Kolodner and T.T. Pham et al., Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer, J Pediatr 138 (2001), 629-635.
140. D.K. Chang, A. Goel, L. Ricciardiello, D.H. Lee, C.L. Chang and J.M. Carethers et al., Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines, Cancer Lett 195 (2003), 243-251.